Related Experiment Video

Updated: Jul 24, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

[Tobacco, infant feeding, and wheezing in the first three years of life]

A Cano Garcinuño1, I Pérez García, J García Puertas

  • 1Centro de Salud de Villamuriel de Cerrato. Palencia. España. acanog@compalencia.org

Anales De Pediatria (Barcelona, Spain : 2003)
|November 26, 2003
PubMed

Insights

Prenatal tobacco smoke exposure significantly increases the risk of wheezing in young children. Avoiding smoke during pregnancy is crucial for preventing childhood respiratory illnesses.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Epidemiology

Context:

  • Wheezing illnesses are common in young children.
  • Avoidable risk factors include tobacco smoke exposure and feeding practices.

Purpose:

  • To assess the impact of prenatal and postnatal tobacco smoke exposure and feeding practices on the risk of wheezing in early childhood.

Summary:

  • A population study of children born between 1998-2002 in Palencia, Spain, identified wheezing episodes in the first 3 years of life.
  • No association was found between wheezing and exclusive breastfeeding for 3 months or postnatal tobacco smoke exposure.
  • Prenatal tobacco smoke exposure was significantly associated with an increased risk of wheezing (Hazard Ratio = 2.54).

Impact:

  • Prenatal tobacco smoke exposure emerges as a primary modifiable risk factor for wheezing in the first three years of life.
  • Findings highlight the importance of smoking cessation programs for pregnant women to reduce childhood respiratory disease burden.
Abstract

More Related Videos

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease02:34

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

Non-Nutritive Suck Parameters Measurements Using a Custom Pressure Transducer System06:19

Non-Nutritive Suck Parameters Measurements Using a Custom Pressure Transducer System

Published on: April 19, 2024

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...